Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- $42.87

down -0.19


15/4/2014 06:40 PM  |  NYSE : NVO  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get NVO Trend Analysis - it has underperformed the S&P 500 by 93%

Partner Headlines

  1. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  2. Salix Among Stocks Getting Support At 10-Week Line

    IBD
  3. Assessing the New Boss at National Oilwell Varco

    GuruFocus
  4. Baxter Splitting In Effort To 'Unlock Trapped Value'

    IBD
  5. Drug, Airline Stocks Top Shortened Weekly Review

    IBD
  6. Baxter To Split Into Two Companies; Stock Jumps

    IBD
  7. Novo Nordisk Upgraded to 'Buy'

    FoxBusiness
  8. UPDATE: Novo Nordisk Reports Results from First Phase 3 Trial with N8-GP

    Benzinga
  9. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  10. Drugmakers Like Jazz, Shire Key To Europe's Recovery

    IBD
  11. European ETFs Flying Under The Radar

    Benzinga
  12. Pharmacyclics Hits High As Imbruvica Launches Big

    IBD
  13. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  14. Stocks Gain For Day, Week

    IBD
  15. Shire PLC: Time to Panic?

    GuruFocus
  16. AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is

    GuruFocus
  17. Bristol-Myers' Diabetes Sale Sharpens Biopharma Focus

    IBD
  18. AstraZeneca Buys Out Bristol-Myers' Diabetes Business

    IBD
  19. Benzinga's Volume Movers

    Benzinga
  20. Sanofi Continues to Struggle on Its Path to Recovery

    GuruFocus
  21. Lilly Pumps $700M into Insulin Manufacturing

    FoxBusiness
  22. Vertex Drug, Fastest Blockbuster, Quickly Fading

    YCharts
  23. Novo Nordisk Initiates European Share Buyback

    Benzinga
  24. Time To Consider Investing In Scandinavia (EWD, EFNL, NORW, EDEN, GXF)

    Benzinga
  25. Novo Nordisk Is Crying Foul In Liability Suit

    YCharts
  26. Novo Nordisk Pushes Ahead In Challenging Year

    IBD
  27. Benzinga's Top Downgrades

    Benzinga
  28. Top 4 Large-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  29. Pharma Stocks: Emerging Brainpower Shift

    YCharts
  30. Pharma’s China-Gate: So Much For Easy Growth

    YCharts
  31. Weekly Preview: Earnings Season Nears The End, China in Focus

    Benzinga
  32. Novo Nordisk (NVO) Drug Delay Draws Option Bears

    SchaeffersResearch
  33. Novo Plunges On FDA Action

    IBD
  34. Novo Nordisk Hit By Diabetes Drug Delay; Sanofi Rises

    IBD
  35. Stocks Little Changed; Ruger Briefly Dips Below Entry

    IBD
  36. Stocks Barely Dip; Starz Takes Off

    IBD
  37. FDA Decision on Diabetes Drug Hurts Novo Nordisk, Helps Sanofi

    YCharts
  38. Stocks Hold Mild Losses; LinkedIn Hits New High

    IBD
  39. Stocks Narrow To Thin Red Line; Generac Backslides

    IBD
  40. Denmark ETF Decked by Novo Nordisk's Slide

    Benzinga
  41. Novo Nordisk Stock Falls, Sanofi Rises On Drug Delay

    IBD
  42. Novo Nordisk Shares Tumble on FDA Letter

    FoxBusiness
  43. Futures Cut Back Early Advance; Novo Nordisk Tumbles On FDA News

    IBD
  44. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  45. Novo Nordisk hit high on Q4

    IBD
  46. Novo Nordisk Earnings Beat Views; Competition Looms

    IBD
  47. Novo Nordisk Stock Hits High After Q4 Profit Beat

    IBD
  48. Stocks Mixed At Midday; Novo Nordisk Hits New High

    IBD
  49. Stocks Mixed At Midday; Novo Nordisk Hits New High

    IBD
  50. Santarus Wins Drug Approval, Offers Bullish Guidance

    IBD
Trading Center